Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers
Authors
Keywords
-
Journal
JAMA Neurology
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-10-10
DOI
10.1001/jamaneurol.2022.3265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Signature laminar distributions of pathology in frontotemporal lobar degeneration
- (2022) Daniel T. Ohm et al. ACTA NEUROPATHOLOGICA
- New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia
- (2022) Marta del Campo et al. Alzheimers & Dementia
- Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis
- (2022) Katheryn A.Q. Cousins et al. ANNALS OF NEUROLOGY
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- New insights into atypical Alzheimer's disease in the era of biomarkers
- (2021) Jonathan Graff-Radford et al. LANCET NEUROLOGY
- Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology
- (2021) Lucia A. A. Giannini et al. Acta Neuropathologica Communications
- Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
- (2021) Julio C. Rojas et al. NEUROLOGY
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Preparing for the age of therapeutic trials in frontotemporal lobar degeneration
- (2021) David Irwin JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Prediagnostic Neurofilament Light Chain Levels in Amyotrophic Lateral Sclerosis
- (2021) Kjetil Bjornevik et al. NEUROLOGY
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia
- (2021) Emma L van der Ende et al. BRAIN
- Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration
- (2021) Zhe Long et al. NEUROBIOLOGY OF AGING
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
- (2021) Andréa L. Benedet et al. JAMA Neurology
- Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
- (2021) Nuole Zhu et al. Translational Neurodegeneration
- Glial profiling of human tauopathy brain demonstrates enrichment of astrocytic transcripts in tau-related frontotemporal degeneration
- (2021) Ashlyn G. Johnson et al. NEUROBIOLOGY OF AGING
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
- (2020) Alexander G Murley et al. BRAIN
- ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Katheryn A Q Cousins et al. BRAIN
- Plasma glial fibrillary acidic protein and neurofilament light chain are measures of disease severity in semantic variant primary progressive aphasia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease
- (2020) Ignacio Illán-Gala et al. NEUROLOGY
- An update on genetic frontotemporal dementia
- (2019) Caroline V. Greaves et al. JOURNAL OF NEUROLOGY
- Neuroinflammation in frontotemporal dementia
- (2019) Fiona Bright et al. Nature Reviews Neurology
- Integrated neurodegenerative disease autopsy diagnosis
- (2018) Edward B. Lee ACTA NEUROPATHOLOGICA
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
- (2018) Lieke H.H. Meeter et al. NEUROLOGY
- A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes
- (2018) Alberto Lleó et al. JAMA Neurology
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study
- (2018) Samir Abu-Rumeileh et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- The clinical spectrum of sporadic and familial forms of frontotemporal dementia
- (2016) Ione O. C. Woollacott et al. JOURNAL OF NEUROCHEMISTRY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Unknown
- (2015) NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
- (2014) Barbara Borroni et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
- (2014) Murray Grossman et al. JAMA Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
- (2013) Jon B. Toledo et al. Alzheimers & Dementia
- Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration
- (2013) Elisabeth M. Wood et al. JAMA Neurology
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- Neuropathological background of phenotypical variability in frontotemporal dementia
- (2011) Keith A. Josephs et al. ACTA NEUROPATHOLOGICA
- A harmonized classification system for FTLD-TDP pathology
- (2011) Ian R. A. Mackenzie et al. ACTA NEUROPATHOLOGICA
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Building an integrated neurodegenerative disease database at an academic health center
- (2011) Sharon X. Xie et al. Alzheimers & Dementia
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
- (2011) Dennis W. Dickson et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
- (2010) H. Seelaar et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started